These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10423645)

  • 21. [Detection and quantitative determination of lectins and viscotoxins in mistletoe preparations].
    Jordan E; Wagner H
    Arzneimittelforschung; 1986 Mar; 36(3):428-33. PubMed ID: 3707660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, ex vivo, and in vivo.
    Heinzerling L; von Baehr V; Liebenthal C; von Baehr R; Volk HD
    J Clin Immunol; 2006 Jul; 26(4):347-59. PubMed ID: 16705487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients.
    Hajto T; Hostanska K; Gabius HJ
    Cancer Res; 1989 Sep; 49(17):4803-8. PubMed ID: 2758413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a mistletoe extract (Iscador QuFrF) on viability and migratory behavior of human peripheral CD4+ and CD8+ T lymphocytes in three-dimensional collagen lattices.
    Nikolai G; Friedl P; Werner M; Niggemann B; Zänker KS
    In Vitro Cell Dev Biol Anim; 1997 Oct; 33(9):710-6. PubMed ID: 9358287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study.
    Bar-Sela G; Wollner M; Hammer L; Agbarya A; Dudnik E; Haim N
    Eur J Cancer; 2013 Mar; 49(5):1058-64. PubMed ID: 23218588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-mistletoe lectin antibodies are produced in patients during therapy with an aqueous mistletoe extract derived from Viscum album L. and neutralize lectin-induced cytotoxicity in vitro.
    Stettin A; Schultze JL; Stechemesser E; Berg PA
    Klin Wochenschr; 1990 Sep; 68(18):896-900. PubMed ID: 2124308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomodulating ability of galactoside-specific lectin standardized and depleted mistletoe extract.
    Beuth J; Stoffel B; Ko HL; Jeljaszewicz J; Pulverer G
    Arzneimittelforschung; 1995 Nov; 45(11):1240-2. PubMed ID: 8929248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a mistletoe preparation with defined lectin content on chronic hepatitis C: an individually controlled cohort study.
    Huber R; Lüdtke R; Klassen M; Müller-Buscher G; Wolff-Vorbeck G; Scheer R
    Eur J Med Res; 2001 Sep; 6(9):399-405. PubMed ID: 11669085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profiles of different breast cancer cells compared with their responsiveness to fermented mistletoe (Viscum album L.) extracts Iscador from oak (Quercus), pine (Pinus), white fir (Abies) and apple tree (Malus) in vitro.
    Eggenschwiler J; Patrignani A; Wagner U; Rehrauer H; Schlapbach R; Rist L; Ramos MH; Viviani A
    Arzneimittelforschung; 2006 Jun; 56(6A):483-96. PubMed ID: 16927530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of cytotoxic proteins from mistletoe (Viscum album L.).
    Jung ML; Baudino S; Ribéreau-Gayon G; Beck JP
    Cancer Lett; 1990 May; 51(2):103-8. PubMed ID: 2344587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular and humoral adjuvant activity of mistletoe extract.
    Bloksma N; Van Dijk H; Korst P; Willers JM
    Immunobiology; 1979 Sep; 156(3):309-18. PubMed ID: 575523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the standardization of mistletoe preparations.
    Wagner H; Jordan E; Feil B
    Oncology; 1986; 43 Suppl 1():16-22. PubMed ID: 3027640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.
    Grossarth-Maticek R; Kiene H; Baumgartner SM; Ziegler R
    Altern Ther Health Med; 2001; 7(3):57-66, 68-72, 74-6 passim. PubMed ID: 11347286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador).
    Grossarth-Maticek R; Ziegler R
    Eur J Med Res; 2008 Mar; 13(3):107-20. PubMed ID: 18499556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iscador Qu for chronic hepatitis C: an exploratory study.
    Tusenius KJ; Spoek JM; Kramers CW
    Complement Ther Med; 2001 Mar; 9(1):12-6. PubMed ID: 11264964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis).
    Janssen O; Scheffler A; Kabelitz D
    Arzneimittelforschung; 1993 Nov; 43(11):1221-7. PubMed ID: 8292069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of anti-mistletoe lectin antibodies in relation to different mistletoe-extracts.
    Stein GM; Stettin A; Schultze J; Berg PA
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S57-9. PubMed ID: 9179370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mistletoe extract-induced effects on immunocompetent cells: in vitro studies.
    Stein GM; Berg PA
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S39-42. PubMed ID: 9179366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Iscador preparations on the reactivity of mouse immune system.
    Gren A
    Neuro Endocrinol Lett; 2009; 30(4):530-4. PubMed ID: 20010495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterisation of immunological reactivity of patients with adverse effects during therapy with an aqueous mistletoe extract.
    Stein GM; Berg PA
    Eur J Med Res; 1999 May; 4(5):169-77. PubMed ID: 10336405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.